UK-based drug maker GlaxoSmithKline NYSE: GSK) will pay about $26.6 million to Georgia as part a national settlement worth $3 billion.
UK-based drug maker GlaxoSmithKline NYSE: GSK) will pay about $26.6 million to Georgia as part a national settlement worth $3 billion.
Tags: atlanta, atlanta business, georgia, georgia business
Leave a reply to Georgia gets $26.6M in GlaxoSmithKline settlement